Medications & Supplements/Prescription Drugs

Cartia XT (Diltiazem) Recalled for Incorrect Expiration Date

Agency Publication Date: January 3, 2022

Summary

Teva Pharmaceuticals USA is recalling 32,316 bottles of Cartia XT (diltiazem hydrochloride extended-release capsules), 120 mg, because the product labels contain an incorrect expiration date. The recall affects 90-count bottles distributed nationwide to pharmacies and through Avista Pharma Inc. No injuries or incidents have been reported in connection with this labeling error.

Risk

An incorrect expiration date may lead consumers to use the medication beyond its intended shelf life, which could result in the drug being less effective at managing blood pressure or heart conditions.

What You Should Do

This recall affects Cartia XT (diltiazem hydrochloride extended-release capsules), 120 mg, sold in 90-capsule bottles with NDC 62037-597-90.
Check your medication label for lot number 100023805 and the expiration date 05/2023 to determine if your product is affected.
If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact the manufacturer for further instructions.
Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions.

Your Remedy Options

You have 2 options:

Option 1: Full Refund

How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund

Option 2: Dispose of Product

How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Cartia XT (Diltiazem Hydrochloride Extended-Release Capsules, USP) 120 mg (90 capsules)

Variants: 120 mg, Extended-Release Capsules, Rx Only

Lot Numbers:

100023805 (Exp. Date 05/2023)

NDC:

62037-597-90

Quantity: 32,316 bottles. Labelled as manufactured by Teva Pharmaceuticals USA, Inc. or Actavis Laboratories FL. Inc. and distributed by Avista Pharma Inc.

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 88936

Status: Resolved

Manufacturer: Teva Pharmaceuticals USA

Sold By: Avista Pharma Inc.; Pharmacies nationwide

Manufactured In: United States

Units Affected: 32316 bottles

Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.

Summary

What You Should Do

This recall affects Cartia XT (diltiazem hydrochloride extended-release capsules), 120 mg, sold in 90-capsule bottles with NDC 62037-597-90.

Check your medication label for lot number 100023805 and the expiration date 05/2023 to determine if your product is affected.

If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact the manufacturer for further instructions.

Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions.

Your Remedy Options

You have 2 options:

Option 1: Full Refund

How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund

Option 2: Dispose of Product

How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Cartia XT (Diltiazem Hydrochloride Extended-Release Capsules, USP) 120 mg (90 capsules)

Variants: 120 mg, Extended-Release Capsules, Rx Only

Lot Numbers:

100023805 (Exp. Date 05/2023)

NDC:

62037-597-90

Quantity: 32,316 bottles. Labelled as manufactured by Teva Pharmaceuticals USA, Inc. or Actavis Laboratories FL. Inc. and distributed by Avista Pharma Inc.